| 1 |
Wang Y, Zeng J, Chen W, Fan J, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer. Noncoding RNA 2023;9:19. [PMID: 36960964 DOI: 10.3390/ncrna9020019] [Reference Citation Analysis]
|
| 2 |
Fang X, Gao F, Yao Q, Xu H, Yu J, Cao H, Li S. Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models. JPM 2023;13:441. [DOI: 10.3390/jpm13030441] [Reference Citation Analysis]
|
| 3 |
Wear KA, Han A, Rubin JM, Gao J, Lavarello R, Cloutier G, Bamber J, Tuthill T. US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. Radiology 2022;305:526-37. [PMID: 36255312 DOI: 10.1148/radiol.220606] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Pitisuttithum P, Treeprasertsuk S. Nonalcoholic fatty liver disease (NAFLD) among older adults. Portal Hypertension & Cirrhosis 2022. [DOI: 10.1002/poh2.31] [Reference Citation Analysis]
|
| 5 |
Liu Y, Guo LW, Xu HF, Kang RH, Zheng LY, Zhang LY, Chen Q, Sun XB, Qiao YL, Zhang SK. Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection. Cancer Prev Res (Phila) 2022;15:767-76. [PMID: 36083859 DOI: 10.1158/1940-6207.CAPR-22-0234] [Reference Citation Analysis]
|
| 6 |
Rodríguez S, Motta FD, Balbinotto Neto G, Brandão A. WAITING LIST FOR LIVER TRANSPLANTATION: CLINICAL AND ECONOMIC BURDEN. Arq Gastroenterol 2022. [DOI: 10.1590/s0004-2803.202204000-87] [Reference Citation Analysis]
|
| 7 |
Rodríguez Villafuerte S, Renato Veríssimo A, Geovanny Mochas L, Andrés Zurita F, Patricio Salazar J. Economic Evaluations of Liver Transplantation as Tools for Decision-Making and Implications in Clinical Practice. Controversies in Liver Transplantation - Recent Challenges and Future Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.104903] [Reference Citation Analysis]
|
| 8 |
Ren Y, Li S, Song Z, Luo Q, Zhang Y, Wang H. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases. Nutrients 2022;14:2303. [PMID: 35684103 DOI: 10.3390/nu14112303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Golabi P, Paik JM, Eberly K, de Avila L, Alqahtani SA, Younossi ZM. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. Ann Hepatol 2022;27:100556. [PMID: 34800721 DOI: 10.1016/j.aohep.2021.100556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 10 |
Fazeli S, Covarrubias Y, Bassirian S, Cuevas J, Fowler K, Vodkin I, Kono Y, Marks R, Loomba R, Taouli B, Sirlin C, Carlos R. Eliciting Patient Preferences for Hepatocellular Carcinoma Screening: A Choice-Based Conjoint Analysis. Journal of the American College of Radiology 2022. [DOI: 10.1016/j.jacr.2022.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Ahmed O, Xu M, Zhou F, Wein AN, Upadhya GA, Ye L, Wong BW, Lin Y, O'Farrelly C, Chapman WC. NRF2 assessment in discarded liver allografts: A role in allograft function and salvage. Am J Transplant 2022;22:58-70. [PMID: 34379880 DOI: 10.1111/ajt.16789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 12 |
Brown C, Aksan N, Muir AJ. MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral. J Clin Gastroenterol 2022;56:902-7. [PMID: 34802021 DOI: 10.1097/MCG.0000000000001642] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Kabaria S, Gupta K, Bhurwal A, Patel AV, Rustgi VK. Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study. Ann Hepatol 2021;22:100284. [PMID: 33160032 DOI: 10.1016/j.aohep.2020.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Ranjan Parida G, Pattnaik G, Behera A. Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight. RJPT 2021. [DOI: 10.52711/0974-360x.2021.01066] [Reference Citation Analysis]
|
| 15 |
He L, Lu A, Qin L, Zhang Q, Ling H, Tan D, He Y. Application of single-cell RNA sequencing technology in liver diseases: a narrative review. Ann Transl Med 2021;9:1598. [PMID: 34790804 DOI: 10.21037/atm-21-4824] [Reference Citation Analysis]
|
| 16 |
DeNofrio JC, Verma M, Kosinski AS, Navarro V, Taddei TH, Volk ML, Bakitas M, Ramchandran K. Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists. Hepatol Commun 2021. [PMID: 34719137 DOI: 10.1002/hep4.1849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Friedrich RP, Cicha I, Alexiou C. Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering. Nanomaterials (Basel) 2021;11:2337. [PMID: 34578651 DOI: 10.3390/nano11092337] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 18 |
Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. Hepatology 2021;74:1509-22. [PMID: 33772833 DOI: 10.1002/hep.31835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Wang Y, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Key Player in Liver Diseases. Hepatology 2021;74:1652-9. [PMID: 33630308 DOI: 10.1002/hep.31765] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 20 |
Lee J, Lee R, Erpelding T, Siddoway RL, Gao J. The effect of water intake on ultrasound tissue characteristics and hemodynamics of adult livers. Clin Exp Hepatol 2021;7:223-30. [PMID: 34295991 DOI: 10.5114/ceh.2021.107068] [Reference Citation Analysis]
|
| 21 |
Desai AP, Greene M, Nephew LD, Orman ES, Ghabril M, Chalasani N, Menachemi N. Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders. Clin Transl Gastroenterol 2021;12:e00372. [PMID: 34142663 DOI: 10.14309/ctg.0000000000000372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Brahmania M, Wiskar K, Walley KR, Celi LA, Rush B. Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis. J Gastroenterol Hepatol 2021;36:1088-94. [PMID: 32562577 DOI: 10.1111/jgh.15153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 23 |
Hussein RM, Sawy DM, Kandeil MA, Farghaly HS. Chlorogenic acid, quercetin, coenzyme Q10 and silymarin modulate Keap1-Nrf2/heme oxygenase-1 signaling in thioacetamide-induced acute liver toxicity. Life Sci 2021;277:119460. [PMID: 33811899 DOI: 10.1016/j.lfs.2021.119460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 24 |
Serrya MS, Nader MA, Abdelmageed ME. Hepatoprotective effect of the tyrosine kinase inhibitor nilotinib against cyclosporine-A induced liver injury in rats through blocking the Bax/Cytochrome C/caspase-3 apoptotic signaling pathway. J Biochem Mol Toxicol 2021;35:1-13. [PMID: 33710703 DOI: 10.1002/jbt.22764] [Reference Citation Analysis]
|
| 25 |
Trujillo MJ, Chen J, Rubin JM, Gao J. Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A review. Clin Imaging 2021;78:22-34. [PMID: 33721575 DOI: 10.1016/j.clinimag.2021.02.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Moura Cunha G, Navin PJ, Fowler KJ, Venkatesh SK, Ehman RL, Sirlin CB. Quantitative magnetic resonance imaging for chronic liver disease. Br J Radiol 2021;94:20201377. [PMID: 33635729 DOI: 10.1259/bjr.20201377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 27 |
Cervo A, Shengir M, Patel K, Sebastiani G. NASH in HIV. Curr HIV/AIDS Rep 2020;17:601-14. [PMID: 32984925 DOI: 10.1007/s11904-020-00531-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 28 |
Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel) 2021;11:98. [PMID: 33435415 DOI: 10.3390/diagnostics11010098] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 29 |
Mokhtari F, Mohebbi SR, Sharifian A, Ramandi M, Razzaghi MR. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases. Gastroenterol Hepatol Bed Bench 2021;14:S10-23. [PMID: 35154598] [Reference Citation Analysis]
|
| 30 |
Alshanketi RM, Jabbad R, Baghlaf B, Al-yamani R, Alsahafi M, Akbar HO, Fallatah HI. Autoimmune Hepatitis Prevalence among Patients from Saudi Arabia with Chronic Liver Disease Referred for Transient Elastography. IJCM 2021;12:251-260. [DOI: 10.4236/ijcm.2021.126022] [Reference Citation Analysis]
|
| 31 |
Asghar MS, Ahsan MN, Rasheed U, Hassan M, Jawed R, Abbas MB, Yaseen R, Ali Naqvi SA, Rizvi H, Syed M. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. Cureus 2020;12:e12294. [PMID: 33520498 DOI: 10.7759/cureus.12294] [Reference Citation Analysis]
|
| 32 |
Bayrak M. Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factors. Aging Male 2020;23:1275-82. [PMID: 32396414 DOI: 10.1080/13685538.2020.1763293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Kataria R, Pickett-blakely O. The Mediterranean Diet in Gastrointestinal and Liver Diseases. Curr Treat Options Gastro 2020;18:718-28. [DOI: 10.1007/s11938-020-00318-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 34 |
Verma M, Kosinski AS, Volk ML, Taddei T, Ramchandran K, Bakitas M, Green K, Green L, Navarro V. Introducing Palliative Care within the Treatment of End-Stage Liver Disease: The Study Protocol of a Cluster Randomized Controlled Trial. J Palliat Med 2019;22:34-43. [PMID: 31486722 DOI: 10.1089/jpm.2019.0121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 35 |
Kaplan DE, Medvedeva E, Serper M. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era. J Viral Hepat 2020;27:1082-92. [PMID: 32484991 DOI: 10.1111/jvh.13340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 36 |
Korbitz PM, Gallagher JP, Samant H, Singh S, Jophlin L, Ingviya T, Manatsathit W. Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta-analysis. Clin Transplant. 2020;e13995. [PMID: 32485008 DOI: 10.1111/ctr.13995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017. Hepatol Commun 2020;4:1769-80. [PMID: 33305148 DOI: 10.1002/hep4.1599] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 38 |
Mahfouz M, Nguyen H, Tu J, Diaz CR, Anjan S, Brown S, Bosire K, Carrasquillo O, Martin P, Jones PD. Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers. Dig Dis Sci 2020;65:2551-61. [PMID: 31813133 DOI: 10.1007/s10620-019-05980-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Kim D, Vazquez-Montesino LM, Escober JA, Fernandes CT, Cholankeril G, Loomba R, Harrison SA, Younossi ZM, Ahmed A. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol 2020;115:1496-504. [PMID: 32496342 DOI: 10.14309/ajg.0000000000000654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 40 |
Ezzedine K, Bennani M, Shourick J, Taieb C. A Method for Designing a Patient Burden Questionnaire in Dermatology. Clin Cosmet Investig Dermatol 2020;13:521-8. [PMID: 32821144 DOI: 10.2147/CCID.S260323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 41 |
Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 42 |
Brattain LJ, Ozturk A, Telfer BA, Dhyani M, Grajo JR, Samir AE. Image Processing Pipeline for Liver Fibrosis Classification Using Ultrasound Shear Wave Elastography. Ultrasound Med Biol 2020;46:2667-76. [PMID: 32622685 DOI: 10.1016/j.ultrasmedbio.2020.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Cortez AR, Morris MC, Brown NG, Winer LK, Safdar K, Poreddy S, Shah SA, Quillin RC 3rd. Is Surgery Necessary? Endoscopic Management of Post-transplant Biliary Complications in the Modern Era. J Gastrointest Surg 2020;24:1639-47. [PMID: 31228080 DOI: 10.1007/s11605-019-04292-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Ahn SB, Powell EE, Russell A, Hartel G, Irvine KM, Moser C, Valery PC. Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis. Hepatol Commun. 2020;4:1279-1292. [PMID: 32923832 DOI: 10.1002/hep4.1536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Zhang X, Kuang G, Wan J, Jiang R, Ma L, Gong X, Liu X. Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol 2020;85:106662. [PMID: 32544869 DOI: 10.1016/j.intimp.2020.106662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 46 |
Oriakhi K, Uadia PO, Shaheen F, Jahan H, Ibeji CU, Iqbal CM. Isolation, characterization, and hepatoprotective properties of betulinic acid and ricinine from Tetracarpidium conophorum seeds (Euphorbiaceae). J Food Biochem 2021;45:e13288. [PMID: 32529649 DOI: 10.1111/jfbc.13288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Qazi Arisar FA, Kamran M, Nadeem R, Jafri W. Impact of Severity of Chronic Liver Disease on Health-Related Economics. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.97933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 48 |
Mariqueo TA, Zúñiga-Hernández J. Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease. Prostaglandins Leukot Essent Fatty Acids 2020;158:102095. [PMID: 32450460 DOI: 10.1016/j.plefa.2020.102095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 49 |
Brahmania M, Renner EL, Coffin CS, Yoshida EM, Wong P, Zeman M, Shah H. Choosing Wisely Canada-Top Five List in Hepatology: Official Position Statement of the Canadian Association for the Study of the Liver (CASL) and Choosing Wisely Canada (CWC). Ann Hepatol 2019;18:165-71. [PMID: 31113586 DOI: 10.5604/01.3001.0012.7908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 50 |
Paik JM, Golabi P, Biswas R, Alqahtani S, Venkatesan C, Younossi ZM. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. Hepatol Commun 2020;4:890-903. [PMID: 32490324 DOI: 10.1002/hep4.1510] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 51 |
Han H, Qin Y, Yu Y, Wei X, Guo H, Ruan Y, Cao Y, He J. Atrial fibrillation in hospitalized patients with end-stage liver disease: temporal trends in prevalence and outcomes. Liver Int 2020;40:674-84. [PMID: 31705572 DOI: 10.1111/liv.14291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 52 |
Cao S, Zhu L, Zhu C, Feng J, Yin J, Lu J, Xu Y, Yang H, Huang Y, Zhang Q. Helicobacter hepaticus infection-induced IL-33 promotes hepatic inflammation and fibrosis through ST2 signaling pathways in BALB/c mice. Biochem Biophys Res Commun 2020;525:654-61. [PMID: 32122655 DOI: 10.1016/j.bbrc.2020.02.139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 53 |
Hindi Z, Congly S, Tang E, Skaro A, Brahmania M. Liver Transplant Tourism. Liver Transpl 2020;26:276-82. [PMID: 31765044 DOI: 10.1002/lt.25692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 54 |
Wang Y, Li XY, Wu LL, Zheng XY, Deng Y, Li MJ, You X, Chong YT, Hao YT. Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data. Eur J Gastroenterol Hepatol 2020;32:120-6. [PMID: 31688313 DOI: 10.1097/MEG.0000000000001592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 55 |
Chu X, Karasinski K, Donellan S, Kaniper S, Wood GC, Shi W, Edwards MA, Soans R, Still CD, Gerhard GS. A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease. Langenbecks Arch Surg 2020;405:165-72. [PMID: 31828503 DOI: 10.1007/s00423-019-01848-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 56 |
Varghese J, Varghese James J, Karthikeyan M, Rasalkar K, Raghavan R, Sukumaran A, Premkumar PS, Eapen CE, Jacob M. Iron homeostasis is dysregulated, but the iron-hepcidin axis is functional, in chronic liver disease. J Trace Elem Med Biol 2020;58:126442. [PMID: 31835128 DOI: 10.1016/j.jtemb.2019.126442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 57 |
Nischalke HD, Lutz P, Bartok E, Krämer B, Langhans B, Frizler R, Berg T, Hampe J, Buch S, Datz C, Stickel F, Hartmann G, Strassburg CP, Nattermann J, Spengler U. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu. J Mol Med (Berl) 2019;97:1589-600. [PMID: 31637480 DOI: 10.1007/s00109-019-01836-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Wirtz TH, Brandt EF, Berres ML. Liver DCs in health and disease. Int Rev Cell Mol Biol 2019;348:263-99. [PMID: 31810555 DOI: 10.1016/bs.ircmb.2019.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 59 |
Terefe Tesfaye B, Gudina EK, Bosho DD, Mega TA. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia. PLoS One 2019;14:e0221806. [PMID: 31469861 DOI: 10.1371/journal.pone.0221806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 60 |
Garvin JH, Ducom J, Matheny M, Miller A, Westerman D, Reale C, Slagle J, Kelly N, Beebe R, Koola J, Groessl EJ, Patterson ES, Weinger M, Perkins AM, Ho SB. Descriptive Usability Study of CirrODS: Clinical Decision and Workflow Support Tool for Management of Patients With Cirrhosis. JMIR Med Inform 2019;7:e13627. [PMID: 31271153 DOI: 10.2196/13627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 61 |
Lu C, White SJ, Ye IB, Mikhail CM, Cheung ZB, Cho SK. The Effects of Liver Disease on Surgical Outcomes Following Adult Spinal Deformity Surgery. World Neurosurg 2019;130:e498-504. [PMID: 31254688 DOI: 10.1016/j.wneu.2019.06.137] [Reference Citation Analysis]
|
| 62 |
Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One 2019;14:e0211811. [PMID: 30840670 DOI: 10.1371/journal.pone.0211811] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 63 |
Nguyen AL, Park H, Nguyen P, Sheen E, Kim YA, Nguyen MH. Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA. Dig Dis Sci 2019;64:698-707. [PMID: 30327963 DOI: 10.1007/s10620-018-5326-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 64 |
Garvin JH, Ducom J, Matheny M, Miller A, Westerman D, Reale C, Slagle J, Kelly N, Beebe R, Koola J, Groessl EJ, Patterson ES, Weinger M, Perkins AM, Ho SB. Descriptive Usability Study of CirrODS: Clinical Decision and Workflow Support Tool for Management of Patients With Cirrhosis (Preprint).. [DOI: 10.2196/preprints.13627] [Reference Citation Analysis]
|
| 65 |
Kwo PY, Wong K. Abnormal Liver Tests. Liver Disease 2019. [DOI: 10.1007/978-3-319-98506-0_12] [Reference Citation Analysis]
|
| 66 |
Ferre-Aracil C, Lledó JL, Aguilera L, Garcia-Paredes A, Rodríguez-Santiago E, Graus J, García-González M, Nuño J, López-Buenadicha A, López-Hervás P, Rodríguez-Gandía M, Gea F, Albillos A. Current allocation policy is favorable for patients with hepatocellular carcinoma waiting for liver transplantation. Dig Liver Dis 2018;50:1345-50. [PMID: 29807872 DOI: 10.1016/j.dld.2018.04.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 67 |
Tharehalli U, Svinarenko M, Kraus JM, Kühlwein SD, Szekely R, Kiesle U, Scheffold A, Barth TFE, Kleger A, Schirmbeck R, Kestler HA, Seufferlein T, Oswald F, Katz SF, Lechel A. YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion. Int J Mol Sci 2018;19:E3801. [PMID: 30501048 DOI: 10.3390/ijms19123801] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 68 |
Desai AP, Mohan P, Roubal AM, Bettencourt R, Loomba R. Geographic Variability in Liver Disease-Related Mortality Rates in the United States. Am J Med 2018;131:728-34. [PMID: 29496501 DOI: 10.1016/j.amjmed.2018.01.047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 69 |
Gan Y, Zheng S, Zhao J, Zhang C, Gao T, Liao W, Fu Q, Fu C. Protein network module-based identification of key pharmacological pathways of Curcuma phaeocaulis Val. acting on hepatitis. Journal of Ethnopharmacology 2018;221:10-9. [DOI: 10.1016/j.jep.2018.03.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Flamm SL. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy. Am J Med Sci. 2018;356:296-303. [PMID: 30286824 DOI: 10.1016/j.amjms.2018.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 71 |
Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin Pharmacother 2018;19:779-93. [PMID: 29708448 DOI: 10.1080/14656566.2018.1465929] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 72 |
Mikolasevic I, Filipec-Kanizaj T, Mijic M, Jakopcic I, Milic S, Hrstic I, Sobocan N, Stimac D, Burra P. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? World J Gastroenterol 2018; 24(14): 1491-1506 [PMID: 29662288 DOI: 10.3748/wjg.v24.i14.1491] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 73 |
Abdullah SM. Prevalence of Hepatitis B and C virus infection and their co-relation with hematological and hepatic parameters in subjects undergoing Premarital Screening in the Jazan Region, Kingdom of Saudi Arabia. Pak J Med Sci 2018;34:316-21. [PMID: 29805400 DOI: 10.12669/pjms.342.14278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 74 |
Rush B, Walley KR, Celi LA, Rajoriya N, Brahmania M. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology 2017;66:1585-91. [PMID: 28660622 DOI: 10.1002/hep.29297] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 75 |
Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 76 |
Scaglione SJ, Metcalfe L, Kliethermes S, Vasilyev I, Tsang R, Caines A, Mumtaz S, Goyal V, Khalid A, Shoham D, Markossian T, Luke A, Underwood H, Cotler SJ. Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database. J Clin Gastroenterol 2017;51:839-44. [PMID: 28383303 DOI: 10.1097/MCG.0000000000000826] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 77 |
Goossens N, Singal AG, King LY, Andersson KL, Fuchs BC, Besa C, Taouli B, Chung RT, Hoshida Y. Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis. Clin Transl Gastroenterol 2017;8:e101. [PMID: 28640287 DOI: 10.1038/ctg.2017.26] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 78 |
Patidar KR, Thacker LR, Wade JB, White MB, Gavis EA, Fagan A, Sterling RK, Fuchs M, Siddiqui MS, Matherly S, Stravitz RT, Sanyal AJ, Puri P, Luketic VA, Bajaj JS. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci 2017;62:1173-9. [PMID: 28258378 DOI: 10.1007/s10620-017-4509-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S103-17. [DOI: 10.1016/j.jacr.2017.02.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 80 |
Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol 2017;15:767-775.e3. [PMID: 28013117 DOI: 10.1016/j.cgh.2016.11.034] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 81 |
Sigrist RMS, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound Elastography: Review of Techniques and Clinical Applications. Theranostics 2017;7:1303-29. [PMID: 28435467 DOI: 10.7150/thno.18650] [Cited by in Crossref: 694] [Cited by in F6Publishing: 733] [Article Influence: 115.7] [Reference Citation Analysis]
|
| 82 |
Verma M, Navarro V. Palliative Care for End-Stage Liver Disease Population. Journal of Palliative Medicine 2017;20:4-4. [DOI: 10.1089/jpm.2016.0375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 83 |
Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis 2016;20:521-34. [PMID: 27373614 DOI: 10.1016/j.cld.2016.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 84 |
Polyzos SA, Mantzoros CS. Nonalcoholic fatty future disease. Metabolism 2016;65:1007-16. [DOI: 10.1016/j.metabol.2015.12.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 85 |
Konerman MA, Loomba R. Editorial: the burden and aetiology of liver cirrhosis, and the risk of death. Aliment Pharmacol Ther 2016;44:202-3. [PMID: 27296684 DOI: 10.1111/apt.13658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 86 |
von Wulffen M, Clark PJ, Macdonald GA, Raj AS, Kendall BJ, Powell EE, Jones MP, Holtmann G. Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability. Aliment Pharmacol Ther 2016;44:68-77. [PMID: 27189900 DOI: 10.1111/apt.13657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 87 |
Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2016;8:166-178. [PMID: 27698966 DOI: 10.15171/mejdd.2016.29] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 88 |
Mellinger J, Fontana RJ. Quality of care metrics in chronic hepatitis B. Hepatology 2016;63:1755-8. [PMID: 26890464 DOI: 10.1002/hep.28500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 89 |
Konerman MA, Brown M, Zheng Y, Lok AS. Dynamic prediction of risk of liver-related outcomes in chronic hepatitis C using routinely collected data. J Viral Hepat 2016;23:455-63. [PMID: 26893198 DOI: 10.1111/jvh.12509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 90 |
Desai AP, Reau N. The Burden of Rehospitalization for Patients With Liver Cirrhosis. Hosp Pract (1995) 2016;44:60-9. [PMID: 26782133 DOI: 10.1080/21548331.2016.1142828] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 91 |
Fallon MB, Kanwal F, El-Serag HB. The Art and Science of Managing Liver Disease. Clin Gastroenterol Hepatol 2015;13:2029-30. [PMID: 26325399 DOI: 10.1016/j.cgh.2015.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
